Your browser doesn't support javascript.
loading
A 3D-printed microfluidic gradient generator with integrated photonic silicon sensors for rapid antimicrobial susceptibility testing.
Heuer, Christopher; Preuss, John-Alexander; Buttkewitz, Marc; Scheper, Thomas; Segal, Ester; Bahnemann, Janina.
Afiliación
  • Heuer C; Institute of Technical Chemistry, Leibniz University Hannover, 30167 Hannover, Germany.
  • Preuss JA; Department of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, 320003 Haifa, Israel. esegal@technion.ac.il.
  • Buttkewitz M; Institute of Technical Chemistry, Leibniz University Hannover, 30167 Hannover, Germany.
  • Scheper T; Institute of Physics, University of Augsburg, 86159 Augsburg, Germany. Janina.bahnemann@uni-a.de.
  • Segal E; Institute of Technical Chemistry, Leibniz University Hannover, 30167 Hannover, Germany.
  • Bahnemann J; Institute of Technical Chemistry, Leibniz University Hannover, 30167 Hannover, Germany.
Lab Chip ; 22(24): 4950-4961, 2022 12 06.
Article en En | MEDLINE | ID: mdl-36412200
With antimicrobial resistance becoming a major threat to healthcare settings around the world, there is a paramount need for rapid point-of-care antimicrobial susceptibility testing (AST) diagnostics. Unfortunately, most currently available clinical AST tools are lengthy, laborious, or are simply inappropriate for point-of-care testing. Herein, we design a 3D-printed microfluidic gradient generator that automatically produces two-fold dilution series of clinically relevant antimicrobials. We first establish the compatibility of these generators for classical AST (i.e., broth microdilution) and then extend their application to include a complete on-chip label-free and phenotypic AST. This is accomplished by the integration of photonic silicon chips, which provide a preferential surface for microbial colonization and allow optical tracking of bacterial behavior and growth at a solid-liquid interface in real-time by phase shift reflectometric interference spectroscopic measurements (PRISM). Using Escherichia coli and ciprofloxacin as a model pathogen-drug combination, we successfully determine the minimum inhibitory concentration within less than 90 minutes. This gradient generator-based PRISM assay provides an integrated AST device that is viable for convenient point-of-care testing and offers a promising and most importantly, rapid alternative to current clinical practices, which extend to 8-24 h.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Silicio / Microfluídica Idioma: En Revista: Lab Chip Asunto de la revista: BIOTECNOLOGIA / QUIMICA Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Silicio / Microfluídica Idioma: En Revista: Lab Chip Asunto de la revista: BIOTECNOLOGIA / QUIMICA Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido